The role of combined antibacterial agents in the complex treatment of inflammatory diseases of female genital organs of mixed etiology

Authors: B.G. Kogan1, G.D. Gordeeva2

1Healthy and Happy Medical Center, Kyiv
2National Medical University named after A.A. Bogomolets, Kyiv

The article presents the results of the combined antimicrobial Ortsipol (WORLD MEDICINE) in inflammatory diseases of the female genital organs of mixed etiology, as well as vaginal capsules Bioselak (ROTAPHARM) for the prevention of antibiotic dysbiotic complications. In 50 patients with indication for antibiotic therapy and Bioselak Ortsipol used in the complex of therapeutic measures in cervicitis, adnexitises mixed etiology. Studying the dynamics of clinical status, laboratory analyzes, data from ultrasound scans of patients studied in the course of treatment and after it possible to establish the high efficacy of this combination. All patients had achieved clinical cure (disappearance of symptoms of acute illness), the frequency of elimination of pathogens was 92.0%.

Keywords: cervicitis, adnexitis, mixed infections, treatment, prevention of dysbiosis vagina Ortsipol, Bioselak.

Article in PDF
ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
Опубліковано в журналі «Сучасна педіатрія. Україна» №8 (120) ’2021
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

Yes
No

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design